院外环境下疑似急性心肌梗死临床路径的诊断准确性
这项前瞻性诊断准确性研究于2019年2月至2020年3月在4个救护车服务和12个急诊科开展,纳入817例急救人员怀疑AMI的患者,院外采集静脉血并以床旁cTn检测(Roche cobas h232)在4小时内完成检测,目标诊断为经2名研究者裁定的1型AMI(104例,12.8%)。在最低风险组界值下,仅肌钙蛋白的曼彻斯特急性冠脉综合征决策工具敏感性98.3%(95%CI 91.1%–100%)、特异性25.5%(21.4%–29.8%);HEART评分敏感性86.4%(75.0%–98.4%)、特异性42.2%(37.5%–47.0%);仅病史和心电图的曼彻斯特工具敏感性100%(96.4%–100%)、特异性3.1%(1.9%–4.7%);仅病史和心电图的HEART评分敏感性95.1%(88.9%–98.4%)、特异性12.1%(9.8%–14.8%)。作者认为,这些工具结合临床判断并经过适当培训,可能有助于增强院外风险分层。
要点
- 817例院外疑似AMI患者中104例(12.8%)确诊1型AMI。
- 仅肌钙蛋白的曼彻斯特工具在最低风险组界值下敏感性98.3%(91.1%–100%)、特异性25.5%(21.4%–29.8%)。
- HEART评分敏感性86.4%(75.0%–98.4%)、特异性42.2%(37.5%–47.0%)。
- 仅病史和心电图的曼彻斯特工具敏感性100%(96.4%–100%)、特异性3.1%(1.9%–4.7%)。
- 仅病史和心电图的HEART评分敏感性95.1%(88.9%–98.4%)、特异性12.1%(9.8%–14.8%)。
适用人群与场景
- 2019年2月至2020年3月在4个救护车服务和12个急诊科纳入的、接受紧急救护车响应且急救人员怀疑AMI的患者。
诊断标准与关键阈值
- 目标诊断为经2名研究者裁定的1型AMI。
- 决策工具在最低风险组界值下评估诊断准确性。
处置流程与药物剂量
- 急救人员记录计算各决策工具所需数据,并在院外采集静脉血样本。
- 样本在4小时内使用床旁cTn检测(Roche cobas h232)完成检测。
研究设计与关键结果
- 前瞻性诊断准确性研究,纳入817例患者,104例(12.8%)发生AMI。
- 仅肌钙蛋白的曼彻斯特急性冠脉综合征决策工具:敏感性98.3%(95%CI 91.1%–100%),特异性25.5%(21.4%–29.8%)。
- HEART评分(病史、心电图、年龄、危险因素、肌钙蛋白):敏感性86.4%(75.0%–98.4%),特异性42.2%(37.5%–47.0%)。
- 仅病史和心电图的曼彻斯特工具:敏感性100%(96.4%–100%),特异性3.1%(1.9%–4.7%)。
- 仅病史和心电图的HEART评分:敏感性95.1%(88.9%–98.4%),特异性12.1%(9.8%–14.8%)。
证据类型、等级与局限
- 证据类型:前瞻性诊断准确性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,结合床旁cTn检测,决策工具可在院外环境识别1型AMI低风险患者。
- 作者认为,与临床判断一起使用并经过适当培训,此类工具可能有助于增强院外风险分层。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Chest pain is one of the most common reasons for emergency ambulance calls. Patients are routinely transported to the hospital to prevent acute myocardial infarction (AMI). We evaluated the diagnostic accuracy of clinical pathways in the out-of-hospital environment. The Troponin-only Manchester Acute Coronary Syndromes decision aid and History, ECG, Age, Risk Factors, Troponin score require cardiac troponin (cTn) measurement, whereas the History and ECG-only Manchester Acute Coronary Syndromes decision aid and History, ECG, Age, Risk Factors score do not.
METHODS: We conducted a prospective diagnostic accuracy study at 4 ambulance services and 12 emergency departments between February 2019 and March 2020. We included patients who received an emergency ambulance response in whom paramedics suspected AMI. Paramedics recorded the data required to calculate each decision aid and took venous blood samples in the out-of-hospital environment. Samples were tested using a point-of-care cTn assay (Roche cobas h232) within 4 hours. The target condition was a diagnosis of type 1 AMI, adjudicated by 2 investigators.
RESULTS: Of 817 included participants, 104 (12.8%) had AMI. Setting the cutoff at the lowest risk group, Troponin-only Manchester Acute Coronary Syndromes had 98.3% sensitivity (95% confidence interval 91.1% to 100%) and 25.5% specificity (21.4% to 29.8%) for type 1 AMI. History, ECG, Age, Risk Factors, Troponin had 86.4% sensitivity (75.0% to 98.4%) and 42.2% specificity (37.5% to 47.0%); History and ECG-only Manchester Acute Coronary Syndromes had 100% sensitivity (96.4% to 100%) and 3.1% specificity (1.9% to 4.7%), whereas History, ECG, Age, Risk Factors had 95.1% sensitivity (88.9% to 98.4%) and 12.1% specificity (9.8% to 14.8%).
CONCLUSION: With point-of-care cTn testing, decision aids can identify patients at a low risk of type 1 AMI in the out-of-hospital environment. When used alongside clinical judgment, and with appropriate training, such tools may usefully enhance out-of-hospital risk stratification.
参考来源
- Alghamdi A, Hann M, Carlton E, et al. Diagnostic Accuracy of Clinical Pathways for Suspected Acute Myocardial Infarction in the Out-of-Hospital Environment. Ann Emerg Med. 2023. PMID: 37306636. doi:10.1016/j.annemergmed.2023.04.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。